 | • レポートコード：B-GIR09D2433 • 出版社/出版日：GlobalInfoResearch / 2019年9月11日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、核医学放射性同位体の世界市場について調べ、まとめました。種類別セグメントは、タリウム-201（Tl-201）、ヨウ素（I-123）、フッ素-18、ルビジウム-82（Rb-82）、その他等、用途別セグメントは、腫瘍、心臓病、リンパ腫、甲状腺、その他等に区分しました。核医学放射性同位体の世界市場概観、メーカー動向、メーカー別核医学放射性同位体シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・核医学放射性同位体の市場概観 ・核医学放射性同位体の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・核医学放射性同位体の企業別販売動向、市場シェア、市場集中度、競争動向 ・核医学放射性同位体の世界市場規模 ・核医学放射性同位体の北米市場分析（アメリカ、カナダ、メキシコ等） ・核医学放射性同位体のアメリカ市場規模推移 ・核医学放射性同位体のカナダ市場規模推移 ・核医学放射性同位体のメキシコ市場規模推移 ・核医学放射性同位体のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・核医学放射性同位体のドイツ市場規模推移 ・核医学放射性同位体のイギリス市場規模推移 ・核医学放射性同位体のロシア市場規模推移 ・核医学放射性同位体のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・核医学放射性同位体の日本市場規模推移 ・核医学放射性同位体の中国市場規模推移 ・核医学放射性同位体の韓国市場規模推移 ・核医学放射性同位体のインド市場規模推移 ・核医学放射性同位体の東南アジア市場規模推移 ・核医学放射性同位体の南米市場分析（ブラジル、アルゼンチン等） ・核医学放射性同位体の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・核医学放射性同位体の種類別分析/販売量、売上、市場シェア（タリウム-201（Tl-201）、ヨウ素（I-123）、フッ素-18、ルビジウム-82（Rb-82）、その他） ・核医学放射性同位体の用途別分析/市場規模（腫瘍、心臓病、リンパ腫、甲状腺、その他） ・核医学放射性同位体の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・核医学放射性同位体の販売チャネル・代理店・貿易業者・ディーラー分析 |
Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.
Scope of the Report:
The worldwide market for Nuclear Medicine Radioisotopes is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Nuclear Medicine Radioisotopes in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami
Siemens Healthcare
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (Rb-82)
Other
Market Segment by Applications, can be divided into
Tumor
Heart Disease
Lymphoma
Thyroid Gland
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Medicine Radioisotopes product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nuclear Medicine Radioisotopes, with price, sales, revenue and global market share of Nuclear Medicine Radioisotopes in 2017 and 2018.
Chapter 3, the Nuclear Medicine Radioisotopes competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medicine Radioisotopes breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Nuclear Medicine Radioisotopes market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Nuclear Medicine Radioisotopes sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Nuclear Medicine Radioisotopes Introduction
1.2 Market Analysis by Type
1.2.1 Thallium-201 (Tl-201)
1.2.2 Iodine (I-123)
1.2.3 Fluorine-18
1.2.4 Rubidium-82 (Rb-82)
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 Tumor
1.3.2 Heart Disease
1.3.3 Lymphoma
1.3.4 Thyroid Gland
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Agfa-Gevaert Group
2.1.1 Business Overview
2.1.2 Nuclear Medicine Radioisotopes Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Braco
2.2.1 Business Overview
2.2.2 Nuclear Medicine Radioisotopes Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Braco Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Cardiarc
2.3.1 Business Overview
2.3.2 Nuclear Medicine Radioisotopes Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Cardiarc Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Cardinal Health
2.4.1 Business Overview
2.4.2 Nuclear Medicine Radioisotopes Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cardinal Health Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 CMR Naviscan (Gamma Medica Inc.)
2.5.1 Business Overview
2.5.2 Nuclear Medicine Radioisotopes Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Curium
2.6.1 Business Overview
2.6.2 Nuclear Medicine Radioisotopes Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Curium Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Digirad
2.7.1 Business Overview
2.7.2 Nuclear Medicine Radioisotopes Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Digirad Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 GE Healthcare
2.8.1 Business Overview
2.8.2 Nuclear Medicine Radioisotopes Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GE Healthcare Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Nordion (Canada)
2.9.1 Business Overview
2.9.2 Nuclear Medicine Radioisotopes Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 NTP Radioisotopes SOC
2.10.1 Business Overview
2.10.2 Nuclear Medicine Radioisotopes Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Positron
2.11.1 Business Overview
2.11.2 Nuclear Medicine Radioisotopes Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Positron Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Segami
2.12.1 Business Overview
2.12.2 Nuclear Medicine Radioisotopes Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Segami Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Siemens Healthcare
2.13.1 Business Overview
2.13.2 Nuclear Medicine Radioisotopes Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Nuclear Medicine Radioisotopes Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Nuclear Medicine Radioisotopes Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Nuclear Medicine Radioisotopes Manufacturer Market Share in 2018
3.3.2 Top 6 Nuclear Medicine Radioisotopes Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Nuclear Medicine Radioisotopes Market Analysis by Regions
4.1 Global Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Regions
4.1.1 Global Nuclear Medicine Radioisotopes Sales and Market Share by Regions (2014-2019)
4.1.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Regions (2014-2019)
4.2 North America Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
4.3 Europe Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
4.5 South America Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
5 North America Nuclear Medicine Radioisotopes by Country
5.1 North America Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Country
5.1.1 North America Nuclear Medicine Radioisotopes Sales and Market Share by Country (2014-2019)
5.1.2 North America Nuclear Medicine Radioisotopes Revenue and Market Share by Country (2014-2019)
5.2 United States Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
5.3 Canada Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
5.4 Mexico Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
6 Europe Nuclear Medicine Radioisotopes by Country
6.1 Europe Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Country
6.1.1 Europe Nuclear Medicine Radioisotopes Sales and Market Share by Country (2014-2019)
6.1.2 Europe Nuclear Medicine Radioisotopes Revenue and Market Share by Country (2014-2019)
6.2 Germany Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
6.3 UK Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
6.4 France Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
6.5 Russia Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
6.6 Italy Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
7 Asia-Pacific Nuclear Medicine Radioisotopes by Country
7.1 Asia-Pacific Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Nuclear Medicine Radioisotopes Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Nuclear Medicine Radioisotopes Revenue and Market Share by Country (2014-2019)
7.2 China Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
7.3 Japan Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
7.4 Korea Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
7.5 India Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
8 South America Nuclear Medicine Radioisotopes by Country
8.1 South America Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Country
8.1.1 South America Nuclear Medicine Radioisotopes Sales and Market Share by Country (2014-2019)
8.1.2 South America Nuclear Medicine Radioisotopes Revenue and Market Share by Country (2014-2019)
8.2 Brazil Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
8.3 Argentina Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
8.4 Colombia Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
9 Middle East and Africa Nuclear Medicine Radioisotopes by Countries
9.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Nuclear Medicine Radioisotopes Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
9.3 Turkey Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
9.4 Egypt Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
9.5 Nigeria Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
9.6 South Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
10 Global Nuclear Medicine Radioisotopes Market Segment by Type
10.1 Global Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Nuclear Medicine Radioisotopes Sales and Market Share by Type (2014-2019)
10.1.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Type (2014-2019)
10.2 Thallium-201 (Tl-201) Sales Growth and Price
10.2.1 Global Thallium-201 (Tl-201) Sales Growth (2014-2019)
10.2.2 Global Thallium-201 (Tl-201) Price (2014-2019)
10.3 Iodine (I-123) Sales Growth and Price
10.3.1 Global Iodine (I-123) Sales Growth (2014-2019)
10.3.2 Global Iodine (I-123) Price (2014-2019)
10.4 Fluorine-18 Sales Growth and Price
10.4.1 Global Fluorine-18 Sales Growth (2014-2019)
10.4.2 Global Fluorine-18 Price (2014-2019)
10.5 Rubidium-82 (Rb-82) Sales Growth and Price
10.5.1 Global Rubidium-82 (Rb-82) Sales Growth (2014-2019)
10.5.2 Global Rubidium-82 (Rb-82) Price (2014-2019)
10.6 Other Sales Growth and Price
10.6.1 Global Other Sales Growth (2014-2019)
10.6.2 Global Other Price (2014-2019)
11 Global Nuclear Medicine Radioisotopes Market Segment by Application
11.1 Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2014-2019)
11.2 Tumor Sales Growth (2014-2019)
11.3 Heart Disease Sales Growth (2014-2019)
11.4 Lymphoma Sales Growth (2014-2019)
11.5 Thyroid Gland Sales Growth (2014-2019)
11.6 Other Sales Growth (2014-2019)
12 Nuclear Medicine Radioisotopes Market Forecast (2019-2024)
12.1 Global Nuclear Medicine Radioisotopes Sales, Revenue and Growth Rate (2019-2024)
12.2 Nuclear Medicine Radioisotopes Market Forecast by Regions (2019-2024)
12.2.1 North America Nuclear Medicine Radioisotopes Market Forecast (2019-2024)
12.2.2 Europe Nuclear Medicine Radioisotopes Market Forecast (2019-2024)
12.2.3 Asia-Pacific Nuclear Medicine Radioisotopes Market Forecast (2019-2024)
12.2.4 South America Nuclear Medicine Radioisotopes Market Forecast (2019-2024)
12.2.5 Middle East and Africa Nuclear Medicine Radioisotopes Market Forecast (2019-2024)
12.3 Nuclear Medicine Radioisotopes Market Forecast by Type (2019-2024)
12.3.1 Global Nuclear Medicine Radioisotopes Sales Forecast by Type (2019-2024)
12.3.2 Global Nuclear Medicine Radioisotopes Market Share Forecast by Type (2019-2024)
12.4 Nuclear Medicine Radioisotopes Market Forecast by Application (2019-2024)
12.4.1 Global Nuclear Medicine Radioisotopes Sales Forecast by Application (2019-2024)
12.4.2 Global Nuclear Medicine Radioisotopes Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Nuclear Medicine Radioisotopes Picture
Table Product Specifications of Nuclear Medicine Radioisotopes
Figure Global Sales Market Share of Nuclear Medicine Radioisotopes by Types in 2018
Table Nuclear Medicine Radioisotopes Types for Major Manufacturers
Figure Thallium-201 (Tl-201) Picture
Figure Iodine (I-123) Picture
Figure Fluorine-18 Picture
Figure Rubidium-82 (Rb-82) Picture
Figure Other Picture
Figure Nuclear Medicine Radioisotopes Sales Market Share by Applications in 2018
Figure Tumor Picture
Figure Heart Disease Picture
Figure Lymphoma Picture
Figure Thyroid Gland Picture
Figure Other Picture
Figure United States Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure France Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure UK Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure China Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure India Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Nuclear Medicine Radioisotopes Revenue (Value) and Growth Rate (2014-2024)
Table Agfa-Gevaert Group Basic Information, Manufacturing Base and Competitors
Table Agfa-Gevaert Group Nuclear Medicine Radioisotopes Type and Applications
Table Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Braco Basic Information, Manufacturing Base and Competitors
Table Braco Nuclear Medicine Radioisotopes Type and Applications
Table Braco Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Cardiarc Basic Information, Manufacturing Base and Competitors
Table Cardiarc Nuclear Medicine Radioisotopes Type and Applications
Table Cardiarc Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Cardinal Health Basic Information, Manufacturing Base and Competitors
Table Cardinal Health Nuclear Medicine Radioisotopes Type and Applications
Table Cardinal Health Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CMR Naviscan (Gamma Medica Inc.) Basic Information, Manufacturing Base and Competitors
Table CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Type and Applications
Table CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Curium Basic Information, Manufacturing Base and Competitors
Table Curium Nuclear Medicine Radioisotopes Type and Applications
Table Curium Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Digirad Basic Information, Manufacturing Base and Competitors
Table Digirad Nuclear Medicine Radioisotopes Type and Applications
Table Digirad Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GE Healthcare Basic Information, Manufacturing Base and Competitors
Table GE Healthcare Nuclear Medicine Radioisotopes Type and Applications
Table GE Healthcare Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Nordion (Canada) Basic Information, Manufacturing Base and Competitors
Table Nordion (Canada) Nuclear Medicine Radioisotopes Type and Applications
Table Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table NTP Radioisotopes SOC Basic Information, Manufacturing Base and Competitors
Table NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Type and Applications
Table NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Positron Basic Information, Manufacturing Base and Competitors
Table Positron Nuclear Medicine Radioisotopes Type and Applications
Table Positron Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Segami Basic Information, Manufacturing Base and Competitors
Table Segami Nuclear Medicine Radioisotopes Type and Applications
Table Segami Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table Siemens Healthcare Nuclear Medicine Radioisotopes Type and Applications
Table Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Nuclear Medicine Radioisotopes Sales by Manufacturer (2017-2018)
Figure Global Nuclear Medicine Radioisotopes Sales Market Share by Manufacturer in 2017
Figure Global Nuclear Medicine Radioisotopes Sales Market Share by Manufacturer in 2018
Table Global Nuclear Medicine Radioisotopes Revenue by Manufacturer (2017-2018)
Figure Global Nuclear Medicine Radioisotopes Revenue Market Share by Manufacturer in 2017
Figure Global Nuclear Medicine Radioisotopes Revenue Market Share by Manufacturer in 2018
Figure Top 3 Nuclear Medicine Radioisotopes Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Nuclear Medicine Radioisotopes Manufacturer (Revenue) Market Share in 2018
Figure Global Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Global Nuclear Medicine Radioisotopes Revenue and Growth Rate (2014-2019)
Table Global Nuclear Medicine Radioisotopes Sales by Regions (2014-2019)
Table Global Nuclear Medicine Radioisotopes Sales Market Share by Regions (2014-2019)
Table Global Nuclear Medicine Radioisotopes Revenue by Regions (2014-2019)
Figure Global Nuclear Medicine Radioisotopes Revenue Market Share by Regions in 2014
Figure Global Nuclear Medicine Radioisotopes Revenue Market Share by Regions in 2018
Figure North America Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Europe Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure South America Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure North America Nuclear Medicine Radioisotopes Revenue and Growth Rate (2014-2019)
Table North America Nuclear Medicine Radioisotopes Sales by Countries (2014-2019)
Table North America Nuclear Medicine Radioisotopes Sales Market Share by Countries (2014-2019)
Figure North America Nuclear Medicine Radioisotopes Sales Market Share by Countries in 2014
Figure North America Nuclear Medicine Radioisotopes Sales Market Share by Countries in 2018
Table North America Nuclear Medicine Radioisotopes Revenue by Countries (2014-2019)
Table North America Nuclear Medicine Radioisotopes Revenue Market Share by Countries (2014-2019)
Figure North America Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2014
Figure North America Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2018
Figure United States Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Canada Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Mexico Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Europe Nuclear Medicine Radioisotopes Revenue and Growth Rate (2014-2019)
Table Europe Nuclear Medicine Radioisotopes Sales by Countries (2014-2019)
Table Europe Nuclear Medicine Radioisotopes Sales Market Share by Countries (2014-2019)
Table Europe Nuclear Medicine Radioisotopes Revenue by Countries (2014-2019)
Figure Europe Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2017
Figure Europe Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2018
Figure Germany Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure UK Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure France Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Russia Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Italy Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Nuclear Medicine Radioisotopes Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Nuclear Medicine Radioisotopes Sales by Countries (2014-2019)
Table Asia-Pacific Nuclear Medicine Radioisotopes Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Nuclear Medicine Radioisotopes Sales Market Share by Countries 2018
Table Asia-Pacific Nuclear Medicine Radioisotopes Revenue by Countries (2014-2019)
Figure Asia-Pacific Nuclear Medicine Radioisotopes Revenue Market Share by Countries 2018
Figure China Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Japan Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Korea Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure India Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Southeast Asia Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure South America Nuclear Medicine Radioisotopes Revenue and Growth Rate (2014-2019)
Table South America Nuclear Medicine Radioisotopes Sales by Countries (2014-2019)
Table South America Nuclear Medicine Radioisotopes Sales Market Share by Countries (2014-2019)
Figure South America Nuclear Medicine Radioisotopes Sales Market Share by Countries in 2018
Table South America Nuclear Medicine Radioisotopes Revenue by Countries (2014-2019)
Table South America Nuclear Medicine Radioisotopes Revenue Market Share by Countries (2014-2019)
Figure South America Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2018
Figure Brazil Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Argentina Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Colombia Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Nuclear Medicine Radioisotopes Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Nuclear Medicine Radioisotopes Sales by Countries (2014-2019)
Table Middle East and Africa Nuclear Medicine Radioisotopes Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Nuclear Medicine Radioisotopes Sales Market Share by Countries in 2018
Table Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Countries (2014-2019)
Table Middle East and Africa Nuclear Medicine Radioisotopes Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2014
Figure Middle East and Africa Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2018
Figure Saudi Arabia Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure UAE Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Egypt Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure Nigeria Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Figure South Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
Table Global Nuclear Medicine Radioisotopes Sales by Type (2014-2019)
Table Global Nuclear Medicine Radioisotopes Sales Share by Type (2014-2019)
Table Global Nuclear Medicine Radioisotopes Revenue by Type (2014-2019)
Table Global Nuclear Medicine Radioisotopes Revenue Share by Type (2014-2019)
Figure Global Thallium-201 (Tl-201) Sales Growth (2014-2019)
Figure Global Thallium-201 (Tl-201) Price (2014-2019)
Figure Global Iodine (I-123) Sales Growth (2014-2019)
Figure Global Iodine (I-123) Price (2014-2019)
Figure Global Fluorine-18 Sales Growth (2014-2019)
Figure Global Fluorine-18 Price (2014-2019)
Figure Global Rubidium-82 (Rb-82) Sales Growth (2014-2019)
Figure Global Rubidium-82 (Rb-82) Price (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Other Price (2014-2019)
Table Global Nuclear Medicine Radioisotopes Sales by Application (2014-2019)
Table Global Nuclear Medicine Radioisotopes Sales Share by Application (2014-2019)
Figure Global Heart Disease Sales Growth (2014-2019)
Figure Global Lymphoma Sales Growth (2014-2019)
Figure Global Thyroid Gland Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Nuclear Medicine Radioisotopes Sales, Revenue and Growth Rate (2019-2024)
Table Global Nuclear Medicine Radioisotopes Sales Forecast by Regions (2019-2024)
Table Global Nuclear Medicine Radioisotopes Market Share Forecast by Regions (2019-2024)
Figure North America Sales Nuclear Medicine Radioisotopes Market Forecast (2019-2024)
Figure Europe Sales Nuclear Medicine Radioisotopes Market Forecast (2019-2024)
Figure Asia-Pacific Sales Nuclear Medicine Radioisotopes Market Forecast (2019-2024)
Figure South America Sales Nuclear Medicine Radioisotopes Market Forecast (2019-2024)
Figure Middle East and Africa Sales Nuclear Medicine Radioisotopes Market Forecast (2019-2024)
Table Global Nuclear Medicine Radioisotopes Sales Forecast by Type (2019-2024)
Table Global Nuclear Medicine Radioisotopes Market Share Forecast by Type (2019-2024)
Table Global Nuclear Medicine Radioisotopes Sales Forecast by Application (2019-2024)
Table Global Nuclear Medicine Radioisotopes Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
先天性心疾患市場：世界及び中国市場分析・予測（～2024年） Congenital Heart Disease Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Congenital Heart Disease industry with a focus on the Chinese market. The report provides key statistics on the market status of the Congenital Heart Dis…- 世界のSPECT放射性医薬品市場予測（～2024年）：メーカー別、地域別、種類・用途別 A Single Photon Emission Computed Tomography (SPECT) scan is a type of nuclear imaging test that shows how blood flows to tissues and organs. Nuclear imaging requires small amounts of radioactive materials called radiopharmaceuticals – injected, inhaled or swallowed – to diagnose disease. SPECT radi…
- 核医学診断市場：世界及び中国市場分析・予測（～2024年） Nuclear Medicine Diagnostics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Nuclear Medicine Diagnostics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Nuclear Medi…
- 世界の核医学システム市場予測（～2024年）：メーカー別、地域別、種類・用途別 Nuclear medicine is a medical specialty that uses radioactive tracers (radiopharmaceuticals) to assess bodily functions and to diagnose and treat disease. Specially designed cameras allow doctors to track the path of these radioactive tracers. Single Photon Emission Computed Tomography or SPECT and …
- 世界の核医学システム市場予測（～2024年）：メーカー別、地域別、種類・用途別 Nuclear medicine is a medical specialty that uses radioactive tracers (radiopharmaceuticals) to assess bodily functions and to diagnose and treat disease. Specially designed cameras allow doctors to track the path of these radioactive tracers. Single Photon Emission Computed Tomography or SPECT and …